PEOPLE - Spectranetics (US) makes appointments:
This article was originally published in Clinica
Spectranetics, a US company which develops technology for interventional cardiovascular therapy, has appointed Paul Samek vice-president for finance and chief financial officer. Spectranetics controller Guy Childs who has been acting CFO, is promoted to director of finance. He reports to Mr Samek, who joins from the Nash Engineering Company.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.